FDA Inspection 1190580 — Pfizer, Inc.
The FDA completed an inspection of Pfizer, Inc. on Oct 28, 2022 in Groton, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 28, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Groton, CT (United States)
Additional details
Sponsor, Contract Research Organization
Need the full FDA record for Pfizer, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.